Huons Global Co., Ltd. (KOSDAQ:084110)

South Korea flag South Korea · Delayed Price · Currency is KRW
27,450
+2,350 (9.36%)
Jun 9, 2026, 3:30 PM KST
Market Cap334.97B -40.7%
Revenue (ttm)845.30B +4.3%
Net Income23.75B -8.8%
EPS1,944.00 -8.9%
Shares Out 12.20M
PE Ratio14.12
Forward PEn/a
Dividend880.00 (3.51%)
Ex-Dividend DateMay 26, 2026
Volume74,885
Open25,400
Previous Close25,100
Day's Range25,400 - 28,000
52-Week Range25,100 - 76,700
Beta0.32
Analystsn/a
Price Targetn/a
Earnings DateMay 12, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami... [Read more]

Sector Healthcare
Founded 1965
Employees 118
Stock Exchange KOSDAQ
Ticker Symbol 084110
Full Company Profile

Financial Performance

In 2025, Huons Global's revenue was 847.45 billion, an increase of 4.18% compared to the previous year's 813.46 billion. Earnings were 28.84 billion, an increase of 11.82%.

Financial Statements